We are live on ! Find out more
CRDF icon

Cardiff Oncology
CRDF

33 hedge funds and large institutions have $1.32M invested in Cardiff Oncology in 2018 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more first-time investments, than exits

New positions opened: 9 | Existing positions closed: 5

75% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 4

14% more funds holding

Funds holding: 29 → 33 (+4)

10% more capital invested

Capital invested by funds: $1.21M → $1.32M (+$115K)

3.76% less ownership

Funds ownership: 5.29% → 1.53% (-3.8%)

Holders
33
Holders Change
+4
Holders Change %
+13.79%
% of All Funds
0.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
7
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Renaissance Technologies
Renaissance Technologies
New York
+$310K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$158K
3
ARTA
A.R.T. Advisors
New York
+$101K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$69.4K
5
DY
Dowling & Yahnke
California
+$49.2K

Top Sellers

1
SM
Sabby Management
Florida
-$471K
2
CH
CVI Holdings
Delaware
-$237K
3
Citadel Advisors
Citadel Advisors
Florida
-$4.15K
4
MAM
Meeder Asset Management
Ohio
-$1.74K
5
Fifth Third Bancorp
Fifth Third Bancorp
Ohio
-$1K
Name Holding Trade Value Shares
Change 		Change in
Stake
AG
26
Advisor Group
Arizona
– -$109 -23 -53%
Morgan Stanley
27
Morgan Stanley
New York
– +$33 +7 +13%
GP
28
Girard Partners
Pennsylvania
– +$52 +11 New
Fidelity Investments
29
Fidelity Investments
Massachusetts
– +$66 +14 New
CFA
30
Carroll Financial Associates
North Carolina
– +$99 +21 New
IP
31
Intellectus Partners
California
– +$133 +28 New
1
2